Company Filing History:
2 out of 37 
1 out of 8 Years Active: 2009-2010
Title: Inventor Spotlight: David Mufson
Introduction
David Mufson is an innovative inventor based in San Francisco, California, with a focus on pharmaceutical formulations. He has contributed significantly to the field with two patents to his name, demonstrating his commitment to advancing medical science through inventive solutions.
Latest Patents
David Mufson's latest patents cater to the development of new antibiotic treatments. One of his key inventions is the **Concentrated Aqueous Azalide Formulations**, which relate to methods of treating various infections by utilizing concentrated azalide antibiotics. This invention outlines a method for creating effective formulations that can address pulmonary, nasopharyngeal, otic, ocular, dermal, and vaginal infections. The formulation is made by dissolving an azalide antibiotic in an aqueous solution containing a strong acid, paving the way for more efficient treatment options.
Another significant patent is the **Charging Fixture with Valves**, which showcases Mufson's versatility in addressing various problems within the pharmaceutical industry and device engineering.
Career Highlights
Throughout his career, David Mufson has collaborated and worked with notable companies, including InSite Vision Corporation and Catalent Pharma Solutions, LLC. His contributions to these organizations reflect his expertise and dedication to innovative practices in pharmaceutical development.
Collaborations
David has worked alongside esteemed colleagues such as Roy D. Archibald and James Frederick Foreman. These collaborations have facilitated a productive environment for innovation and have allowed Mufson to leverage his skills effectively within the industry.
Conclusion
David Mufson is a distinguished inventor whose work in antibiotic formulations highlights the importance of innovation in medicine. His patents not only demonstrate his technical skills but also his commitment to improving healthcare solutions. With a focus on tackling infections, Mufson's contributions are significant for both the scientific community and patient care.